Detailed clinicopathological characterization of progressive alopecia areata patients treated with i.v. corticosteroid pulse therapy toward optimization of inclusion criteria

Journal of Dermatology

Volumn 41, Issue 11, 2014, Pages 957-963

  Sato, Misato ^a   Amagai, Masayuki ^a   Ohyama, Manabu ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alopecia areata; Dermoscopy; Hair pull test; Histopathology; i.v. corticosteroid pulse therapy

Indexed keywords

METHYLPREDNISOLONE; GLUCOCORTICOID;

ADOLESCENT; ADULT; ALOPECIA AREATA; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG PULSE THERAPY; EPILUMINESCENCE MICROSCOPY; FEMALE; FOLLOW UP; HAIR FOLLICLE; HAIR LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; TREATMENT OUTCOME; MIDDLE AGED; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY; SCALP; YOUNG ADULT;

ADOLESCENT; ADULT; ALOPECIA AREATA; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PATIENT SELECTION; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; SCALP; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84914173398     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12637     Document Type: Article

References (30)

1. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-188, quiz 189-190.
2. Ito T. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata. Clin Dev Immunol 2013; 2013: 348546.
3. Arase S, Tsuboi R, Yamazaki M et al. Japanese Dermatological Association's guidelines for the management of alopecia areata 2010. Jpn J Dermatol 2010; 120: 1841-1859 (in Japanese).
4. Ohyama M. Management of hair loss disorders. Dermatol Sinica 2010; 28: 139-145.
5. Messenger AG, McKillop J, Farrant P, McDonagh AJ, Sladden M. British Association of Dermatologists' guidelines for the management of alopecia areata 2012. Br J Dermatol 2012; 166: 916-926.
6. Perriard-Wolfensberger J, Pasche-Koo F, Mainetti C, Labarthe MP, Salomon D, Saurat JH. Pulse of methylprednisolone in alopecia areata. Dermatology 1993; 187: 282-285.
7. Kiesch N, Stene JJ, Goens J, Vanhooteghem O, Song M. Pulse steroid therapy for children's severe alopecia areata? Dermatology 1997; 194: 395-397.
8. Friedli A, Labarthe MP, Engelhardt E, Feldmann R, Salomon D, Saurat JH. Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J Am Acad Dermatol 1998; 39: 597-602.
9. Seiter S, Ugurel S, Tilgen W, Reinhold U. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 2001; 202: 230-234.
10. Tsai YM, Chen W, Hsu ML, Lin TK. High-dose steroid pulse therapy for the treatment of severe alopecia areata. J Formos Med Assoc 2002; 101: 223-226.
11. Assouly P, Reygagne P, Jouanique C et al. Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients. Ann Dermatol Venereol 2003; 130: 326-330.
12. Nakajima T, Inui S, Itami S. Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology 2007; 215: 320-324.
13. Luggen P, Hunziker T. High-dose intravenous corticosteroid pulse therapy in alopecia areata: own experience compared with the literature. J Dtsch Dermatol Ges 2008; 6: 375-378.
14. Efentaki P, Altenburg A, Haerting J, Zouboulis CC. Medium-dose prednisolone pulse therapy in alopecia areata. Dermatoendocrinol 2009; 1: 310-313.
15. Im M, Lee SS, Lee Y et al. Prognostic factors in methylprednisolone pulse therapy for alopecia areata. J Dermatol 2011; 38: 767-772.
16. Staumont-Salle D, Vonarx M, Lengrand F, Segard M, Delaporte E. Pulse corticosteroid therapy for alopecia areata: long-term outcome after 10 years. Dermatology 2012; 225: 81-87.
17. Acikgoz G, Ozmen I, Cayirli M, Yeniay Y, Kose O. Pulse methylprednisolone therapy for the treatment of extensive alopecia areata. J Dermatolog Treat 2014; 25: 164-166.
18. Inui S, Nakajima T, Itami S. Dry dermoscopy in clinical treatment of alopecia areata. J Dermatol 2007; 34: 635-639.
19. Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol 1993; 28: 755-763.
20. Frishberg DP, Sperling LC, Guthrie VM. Transverse scalp sections: a proposed method for laboratory processing. J Am Acad Dermatol 1996; 35: 220-222.
21. Watabe-Okada E, Amagai M, Ohyama M. Histopathological investigation of clinically non-affected perilesional scalp in alopecias detected unexpected spread of disease activities. J Dermatol 2014; 41: 802-807.
22. Olsen E, Hordinsky M, McDonald-Hull S et al. Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation. J Am Acad Dermatol 1999; 40: 242-246.
23. Sato-Kawamura M, Aiba S, Tagami H. Acute diffuse and total alopecia of the female scalp. A new subtype of diffuse alopecia areata that has a favorable prognosis. Dermatology 2002; 205: 367-373.
24. Burton JL, Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol 1975; 55: 493-496.
25. Olsen EA, Hordinsky MK, Price VH et al. Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-447.
26. Migita K, Eguchi K, Kawabe Y et al. Apoptosis induction in human peripheral blood T lymphocytes by high-dose steroid therapy. Transplantation 1997; 63: 583-587.
27. Whiting DA. Histopathologic features of alopecia areata: a new look. Arch Dermatol 2003; 139: 1555-1559.
28. Barahmani N, Schabath MB, Duvic M. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009; 61: 581-591.
29. Shin BS, Furuhashi T, Nakamura M, Torii K, Morita A. Impaired inhibitory function of circulating CD4(+)CD25(+) regulatory T cells in alopecia areata. J Dermatol Sci 2013; 70: 141-143.
30. Tosti A, Piraccini BM, Vincenzi C, Misciali C. Permanent alopecia after busulfan chemotherapy. Br J Dermatol 2005; 152: 1056-1058.